Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Genes|November 10, 2019
<i>NOP53</i> as A Candidate Modifier Locus for Familial Non-Medullary Thyroid CancerAida Orois, Sudheer K Gara, Mireia Mora, et al.Journal of Experimental & Clinical Cancer Research : CR|November 17, 2023
Targeting FAcilitates Chromatin Transcription complex inhibits pleural mesothelioma and enhances immunotherapyAnand Singh, Nathanael Pruett, Shivani Dixit, et al.Surgery|September 17, 2019
Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancyFloryne O Buishand, Yi Liu-Chittenden, Yu Fan, et al.Oncotarget|September 26, 2018
Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of responseNaris Nilubol, Myriem Boufraqech, Lisa Zhang, et al.The Journal of Investigative Dermatology|October 1, 2010
Expression of the collagen VI α5 and α6 chains in normal human skin and in skin of patients with collagen VI-related myopathiesPatrizia Sabatelli, Sudheer K Gara, Paolo Grumati, et al.Cancer Medicine|March 14, 2015
Phase I trial of systemic intravenous infusion of interleukin-13-Pseudomonas exotoxin in patients with metastatic adrenocortical carcinomaYi Liu-Chittenden, Meenu Jain, Parag Kumar, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 7, 2024
Genome-Wide Analysis Identifies Nuclear Factor 1C as a Novel Transcription Factor and Potential Therapeutic Target in SCLCVivek Shukla, Haitao Wang, Lyuba Varticovski, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2020
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural MesotheliomaEmily S Reardon, Vivek Shukla, Sichuan Xi, et al.Pageof 1